Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bulk deals : Vanguard Group buys shares worth Rs 1000 crore in 7 companies
On September 20, Vanguard Group bought shares worth around Rs 1000 crore in seven Indian listed companies via a bulk deal. Along with this, UBS Principal Capital Asia Limited sold stakes in various companies on the same day. The Vanguard Group Inc A/C Vanguard Total International Stock Index Fund
UBS Offloads Shares Worth Rs 480 Crore In Four Companies
UBS Principal Capital Asia Ltd. sold stakes in Concord Biotech Ltd., Five-Star Bus Fin Ltd., IIFL Securities Ltd. and Marksans Pharma Ltd. worth Rs 480 crore, according to the bulk deal data on the NSE. Concord had 7.4 lakh shares sold by UBS, representing a 0.7% stake at Rs 2589.86 apiece, aggregating to a total value of 191 crore.
Vanguard sells shares of 7 companies worth Rs 998 cr via block deals
US-based financial services company Vanguard Group on Friday bought shares of seven companies including Concord Biotech, Five-Star Business Finance and Marksans Pharma for Rs 998 crore through open market transactions.
Vanguard Group Buys Rs 998 Cr Shares in 7 Companies
Vanguard Group, a US-based financial services company, has purchased shares in seven Indian companies, including Concord Biotech and Five-Star Business Finance, for a total of Rs 998 crore.
Vanguard Group Acquires Rs 998 Crore in Indian Companies
US-based financial services company Vanguard Group acquired shares worth Rs 998 crore in seven Indian companies via open market transactions on the NSE. Concurrently, Zurich-based UBS Group AG sold shares worth Rs 479.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale was in Concord Biotech, worth Rs 192 crore at a 15% premium.
Vanguard Group sells shares of 7 companies worth Rs 998 cr
US-based financial services company Vanguard Group on Friday bought shares of seven companies including Concord Biotech, Five-Star Business Finance and Marksans Pharma for Rs 998 crore through open ma
1d
Breakout stocks to buy or sell: Reliance Infra to Prism Johnson — Sumeet Bagadia recommends five shares to buy today
Sumeet Bagadia recommends five shares to buy today — Marksans Pharma, Concord Biotech, Magadh Sugar, Prism Johnson, and ...
1d
Discovering Jai And 2 Hidden Indian Small Caps with Strong Financials
Over the last 7 days, the Indian market has remained flat, with notable gains of 3.5% in the Utilities sector. Despite this ...
ndtvprofit
2d
Stock Market Today: All You Need To Know Going Into Trade On Sept. 23
Bank Nifty Options Sept. 25 Expiry: Maximum call open Interest at 54,000 and maximum put open interest at 52,000. Securities ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Would-be assassin charged
Gets 2-yrs for role in fraud
Woman dies in 'suicide pod’
Food packaging cancer risk
‘Trump Train’ jury verdict
Phoenix breaks heat record
Severe obesity on the rise
Pres candidates' security bill
To shut down TikTok Music
Outlaws guitarist dies
Haitian group files complaint
Study about oceans' acidity
OR removes 1,200+ voters
InfoWars to be auctioned off
X account hacked
Retiring after 14 seasons
Recalls 41K+ motorcycles
Gives union more voting time
NC sending absentee ballots
Pac-12 sues Mountain West
PA county ballot ruling
Foreign incentives offer?
Dali owner, operator sued
1st NL East title since 2011
Partners with Google
ISR: Hezbollah leader killed
EEOC blocked on rules
Johnny Cash statue unveiled
Executed by lethal injection
Rioter mistakenly released
$375M military aid to UKR
Feedback